original

Biden Signs Order to Curb China in Biotechnology Following Chip Bill

若离

若离

· 9月13日

The US government is reported to introduce new regulations next month to prohibit American companies from exporting chipmaking equipment to Chinese factories that produce advanced semiconductors with sub-14 nanometer processes.

BEIJING, September 12  (TMTPOST)— The U.S. government is expanding its curb in China to more key strategic sectors. 

Source: Visual China

U.S. President Biden signed an executive order Monday to launch a National Biotechnology and Biomanufacturing Initiative, and two days later, the government agencies will announce a wide range of new investments and resources that will allow the United States to harness the full potential of biotechnology and biomanufacturing and advance Biden’s Executive Order, according to a White House statement.

The statement stressed importance of biomanufacturing, a process that involves program microbes to make specialty chemicals and compounds. It cited industry analysis which suggests that bioengineering could account for more than a third of global output of manufacturing industries before the end of the decade—almost $30 trillion in terms of value.

The new initiative will accelerate biotechnology innovation and grow America’s bioeconomy across multiple sectors, including health, agriculture, and energy, drive advances in biomanufacturing that substitute fragile supply chains from abroad with strong chains at home, improve food and energy security, and drive agricultural innovation while mitigating the impacts of climate change, the White House said.

The executive order confirms recent report about the Biden administration’s new efforts targeting China. Biden is seeking to boost U.S. biomanufacuturing through his new order as Covid-19 created a sense of urgency within the administration around developing a clear, consistent industrial strategy, Bloomberg quoted people familiar with the matter last weekend.

While not specifying China in the statement, the White House did suggest overseas’ risks. “The United States has relied too heavily on foreign materials and bioproduction, and our past off-shoring of critical industries, including biotechnology, threatens our ability to access materials like important chemicals and active pharmaceutical ingredients”, though American maintained its strength in bioeconomy, the statement wrote.

Two weeks ago, Biden signed a bipartisan bill CHIPS and Science Act of 2022 into law, providing $52.7 billion in subsidies for U.S. semiconductor production, research and development. The bill was deemed as Washington’s latest attempt to boost the U.S.’s competitiveness with China's science and technology. Wang Wenbin, a spokesperson of Foreign Ministry, soon expressed China’s firm opposition against the bill for it promotes differential industrial policies which include terms limiting relevant companies’ normal investment and trade in China. Wang warns that the bill would distort the global semiconductor supply chains and disrupt international trade. “Creating restrictions and decoupling would hurt others without benefiting oneself,” he added.

However, Washington seems to overlook reinforce its restriction. The U.S. Commerce Department plans to introduce new regulations next month to prohibit American companies from exporting chipmaking equipment to Chinese factories that produce advanced semiconductors with sub-14 nanometer processes without the department’s permission, Reuters sources revealed on Monday. Last month, U.S. officials has asked AMD and Nvidia not to sell two top computing chips for artificial intelligence to their Chinese customers unless these two chip giants obtain the Commerce Department’s licenses.

本文系作者若离授权钛媒体发表,并经钛媒体编辑,转载请注明出处、作者和本文链接
本文观点仅代表作者本人,钛媒体平台仅对用户提供信息及决策参考,本文不构成投资建议。
想和千万钛媒体用户分享你的新奇观点和发现,点击这里投稿 。创业或融资寻求报道,点击这里

敬原创,有钛度,得赞赏

”支持原创,赞赏一下“
钛粉18902 有颜有钱535711 钛粉29232 钛小773590 钛粉07914 钛粉65687
547人已赞赏 >
547换成打赏总人数547人赞赏钛媒体文章
关闭弹窗

挺钛度,加点码!

  • ¥ 5
  • ¥ 10
  • ¥ 20
  • ¥ 50
  • ¥ 100

支付方式

确认支付
关闭弹窗

支付

支付金额:¥6

关闭弹窗
sussess

赞赏金额:¥ 6

赞赏时间:2020.02.11 17:32

关闭弹窗 关闭弹窗

注册邮箱未验证

我们已向下方邮箱发送了验证邮件,请查收并按提示验证您的邮箱。

如果您没有收到邮件,请留意垃圾邮件箱。

更换邮箱

您当前使用的邮箱可能无法接收验证邮件,建议您更换邮箱

账号合并

经检测,你是“钛媒体”和“商业价值”的注册用户。现在,我们对两个产品因进行整合,需要您选择一个账号用来登录。无论您选择哪个账号,两个账号的原有信息都会合并在一起。对于给您造成的不便,我们深感歉意。